Thursday, May 15, 2008

FDA approves new NovoSeven product

On May, 13 the Food and Drug Administration (FDA) approved Novo Nordisk's new formulation of NovoSeven(R)RT recombinant factor VIIa product. What makes the new Novo so novel? The RT is for room temperature. RT can be stored at room temperature. According to the press release the new NovoSeven will be available in higer concentrations for smaller infusion volumes.

From the Press Release:

NovoSeven(R) RT has been manufactured to be room temperature stable (from 36 degrees F to 77 degrees F outside a refrigerator). The new formulation does not require refrigeration and can be moved in and out of the refrigerator. In addition, NovoSeven(R) RT has a higher concentration for lower infusion volumes and quick administration. The needed infusion amount is almost half of that needed with the original NovoSeven(R).

No comments: